Search Results - Benjamin Yoder, PharmD, BCOP

Early Weight Gain as a Risk Factor for Increased Maximum Weight Gain Among Patients With NSCLC on Lorlatinib and Other ALK Tyrosine Kinase Inhibitors by Alexander S. Watson, MD, DPhil, Alyse W. Staley, MS, Benjamin Yoder, PharmD, BCOP, Sean J. Iwamoto, MD, Vida Alami, BA, Erin L. Schenk, MD, PhD, Tejas Patil, MD, D. Ross Camidge, MD, PhD, John M. Taormina, MD

Get full text